Virax Biolabs Group Ltd 20-F for FY2023
Virax Biolabs Group Ltd (VRAX)
20-F
2023-06-14
For: 2023-03-31
View Original
Added on
April 08, 2026
About this 20-F
Virax Biolabs Group Ltd filed this 20-F on June 14, 2023, covering the fiscal year ended March 31, 2023 (FY2023).
Headline figures
Fiscal year ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8561
- Net loss
- $5.46M
- compared with a net loss of $1.71M a year earlier
- Diluted EPS
- -$0.51
- compared with -$0.18 a year earlier